Veroli, Italy

Gianandrea Quattrociocchi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianandrea Quattrociocchi. Retrieved from https://idiyas.com/inventor/gianandrea-quattrociocchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gianandrea Quattrociocchi: Innovator in Pharmaceutical Synthesis

Introduction

Gianandrea Quattrociocchi is a notable inventor based in Veroli, Italy. He has made significant contributions to the field of pharmaceutical synthesis, particularly with his innovative processes. His work has implications for the development of important medicinal compounds.

Latest Patents

Quattrociocchi holds a patent for a process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline. This invention provides a new method for synthesizing a polymorph of this compound, which is substantially pure of any impurities. The polymorph of 7-chloro-4-(piperazin-1-yl)-quinoline is also useful in the synthesis of piperaquine or its pharmaceutically acceptable salts. He has 1 patent to his name.

Career Highlights

Gianandrea Quattrociocchi is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the synthesis of complex pharmaceutical compounds.

Collaborations

Quattrociocchi has collaborated with notable colleagues such as Silvia Armaroli and Roberto Castagnani. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Gianandrea Quattrociocchi is a distinguished inventor whose work in pharmaceutical synthesis has made a significant impact. His innovative processes continue to influence the development of important medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…